The company develops advanced medical imaging technologies and relies on research capabilities from Purdue University and Vibronix. Its current research includes optical imaging methods for bacterial antibiotic-resistance screening and renal intraoperative puncture navigation. The article reports 威邦震电 completed an A+ round financing of nearly RMB 100 million. The financing proceeds will be used to commercialize the company’s spectral-analysis products, accelerate commercial traction, iterate industrial solutions, and advance ultra-multiplex immunohistochemistry applications. No operating metrics, founding year, or location are provided in the article.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Jun 2024